STOCK TITAN

Vigil Neuroscience to Present at 2022 Wedbush PacGrow Healthcare Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vigil Neuroscience, a clinical-stage biotechnology firm (Nasdaq: VIGL), announced its participation in the 2022 Wedbush PacGrow Healthcare Virtual Conference on August 9, 2022, at 11:30 a.m. ET. The management team will engage in a fireside chat to discuss the company’s focus on microglia-targeted therapies for neurodegenerative diseases. Investors can access the live webcast through the ‘Events & Presentations’ section of Vigil's website, with an archived replay available for 90 days after the event.

The company aims to restore microglial function to develop precision-based treatments.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that members of the management team will participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 9, 2022 at 11:30 a.m. ET.

To access a live webcast of this presentation, please visit “Events & Presentations” in the “Investors” section of the Vigil website at www.vigilneuro.com.   An archived replay will be available there for approximately 90 days following the presentation.

About Vigil Neuroscience
Vigil Neuroscience is a microglia-focused therapeutics company focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in our efforts to develop precision-based therapies to improve the lives of patients and their families.

Internet Posting of Information
Vigil Neuroscience routinely posts information that may be important to investors in the 'Investors' section of its website at https://www.vigilneuro.com. The company encourages investors and potential investors to consult our website regularly for important information about Vigil Neuroscience.


FAQ

When is Vigil Neuroscience participating in the Wedbush PacGrow Healthcare Virtual Conference?

Vigil Neuroscience will participate in the conference on August 9, 2022, at 11:30 a.m. ET.

How can I access the live presentation of Vigil Neuroscience at the conference?

The live presentation can be accessed through the 'Events & Presentations' section on Vigil Neuroscience's website.

What is the focus of Vigil Neuroscience's research?

Vigil Neuroscience focuses on developing therapies targeting microglia for treating neurodegenerative diseases.

Will there be a replay available for the Vigil Neuroscience conference presentation?

Yes, an archived replay will be available for approximately 90 days following the presentation.

What is the ticker symbol for Vigil Neuroscience?

The ticker symbol for Vigil Neuroscience is VIGL.

Vigil Neuroscience, Inc.

NASDAQ:VIGL

VIGL Rankings

VIGL Latest News

VIGL Stock Data

69.09M
31.99M
21.27%
80.16%
1.29%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
WATERTOWN